Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses. - Test2 - elhamkhani - TriplyDB

Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses.

Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses.

http://www.wikidata.org/entity/Q30964404

about

Semiphysiologically based pharmacokinetic model for midazolam and CYP3A mediated metabolite 1-OH-midazolam in morbidly obese and weight loss surgery patients.Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma Population pharmacokinetic and pharmacodynamic analysis of BIIB023, an anti-TNF-like weak inducer of apoptosis (anti-TWEAK) monoclonal antibody.Population pharmacokinetics of lenalidomide in multiple myeloma patients.Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials.Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection.Population pharmacokinetics of recombinant coagulation factor VIII-SingleChain in patients with severe hemophilia A.Body weight, gender and pregnancy affect enantiomer-specific ketorolac pharmacokinetics.Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals.Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment.Increased cortisol metabolism in women with pregnancy-related hypertension.

P2860

Q36506472-7DB05FB7-D46B-43E8-864D-8363D88B65A1 Q36805228-9DB56FB6-FA69-4631-A7EA-B96BDE709B0E Q37030693-D20A2990-8125-4CA5-92D5-7F5E7E8C7E9C Q39048427-80D626F6-57C2-4CE9-BE8B-7D59C4D2A560 Q39357557-D143C56E-448A-4028-9529-C63DA3762BC9 Q39675766-B3F3D0AC-44E0-4916-8C06-E54F49E2BB2C Q45865167-987452F9-4397-4781-8E6C-8BE177589842 Q47219276-C8970629-AF9A-4957-B3DC-DFF7A88F4A2F Q47603883-4536747E-F424-4933-9D58-FBF5EF404D47 Q47689257-CF5A1C02-EBF8-4198-A338-49B86E5A351F Q52317955-306D958C-C70F-4F2A-86B2-1521F393F3DF Q55340062-0CFEB245-B349-4235-8485-9ADFC844582A

P2860

Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses.

http://www.wikidata.org/entity/Q30964404

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Incorporation of concentration ...... tion pharmacokinetic analyses.

@ast

Incorporation of concentration ...... tion pharmacokinetic analyses.

@en

type

label

Incorporation of concentration ...... tion pharmacokinetic analyses.

@ast

Incorporation of concentration ...... tion pharmacokinetic analyses.

@en

prefLabel

Incorporation of concentration ...... tion pharmacokinetic analyses.

@ast

Incorporation of concentration ...... tion pharmacokinetic analyses.

@en

P1433

Q30964404-EBE9AC62-056A-4837-8D24-FA4CDF9F0F86

P1476

Q30964404-B5E263C5-0D34-4FB7-BA60-79CEEBF4DB2E

P2093

Q30964404-2DA3339E-2BA0-4D90-A5AA-D0F4EA45009A

Q30964404-52F35196-54D8-4202-96CB-0BD5C8525232

Q30964404-58A5B95D-FCCB-4898-B867-16C0572982A1

Q30964404-92921869-D2CE-4AD5-A886-D1B2EB732DBE

Q30964404-AAD12CEB-ABD3-4FD9-A539-97292CB2415B

Q30964404-D81EBE85-033B-4B1E-B78A-C020F24FC3C6

Q30964404-F696935C-32B7-4024-8955-105F91A3DDA3

P2860

Q30964404-02A02C08-3093-4971-9C45-E2C1504768F2

Q30964404-10F9C46B-CA57-4786-9713-F62C39A84A1A

Q30964404-2AD4030A-3E9A-4854-92B5-AF7DC90BC97F

Q30964404-3829652E-F240-4A0A-9095-BECC506974D1

Q30964404-401A801D-ED91-4982-B93C-02C3DC945D8C

Q30964404-47ED8018-33A8-49B5-BB1E-F8B48F0E424E

Q30964404-553C249E-6448-42B9-9DBB-3EA13684AE98

Q30964404-5A03AF7F-E626-4D74-983E-F6A558A31D23

Q30964404-61FD5826-3B2B-437C-89E8-FB5940248BA4

Q30964404-620B3818-83A9-4261-B58B-BFB736B4ADC6

P304

Q30964404-53D75827-7B1A-4538-A997-5DAA7B81C80E

P31

Q30964404-E21A9814-3ED2-4C50-BD1D-98D78C681C2E

P356

Q30964404-FA071855-B34B-4B24-8E3F-EDCDB6F7FE0D

P433

Q30964404-1F6ABA29-959F-4E63-A0C8-9DC4BC39959F

P478

Q30964404-0A702C9E-C0F0-4D24-85B5-47822A2ABCD6

P577

Q30964404-90B0A17F-3F0C-4174-ABCE-1BBC9786E67F

P5875

Q30964404-281EEADF-1CC7-42FC-8356-3267AC756236

P698

Q30964404-5D335C67-5C29-4880-97A6-592DF100220C

P932

Q30964404-29B4EAF4-D514-4A3E-92AA-0D764578AD4E

P356

P1433

Pharmacology research & perspectives

P1476

Incorporation of concentration ...... tion pharmacokinetic analyses.

@en

P2093

Alwin D R Huitema

http://www.w3.org/2001/XMLSchema#string

Bas Thijssen

http://www.w3.org/2001/XMLSchema#string

Hilde Rosing

http://www.w3.org/2001/XMLSchema#string

Jan H M Schellens

http://www.w3.org/2001/XMLSchema#string

Jos H Beijnen

http://www.w3.org/2001/XMLSchema#string

Robert S Jansen

http://www.w3.org/2001/XMLSchema#string

Ron J Keizer

http://www.w3.org/2001/XMLSchema#string

P2860

Ways to fit a PK model with some data below the quantification limit.

Impact of censoring data below an arbitrary quantification limit on structural model misspecification.

Likelihood based approaches to handling data below the quantification limit using NONMEM VI.

A simple and sensitive assay for the quantitative analysis of paclitaxel and metabolites in human plasma using liquid chromatography/tandem mass spectrometry.

A novel and sensitive method for ethinylestradiol quantification in human plasma by high-performance liquid chromatography coupled to atmospheric pressure photoionization (APPI) tandem mass spectrometry: application to a comparative pharmacokinetics

Liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry method for the quantification of pregabalin in human plasma.

Handling data below the limit of quantification in mixed effect models.

The bioanalysis of vinorelbine and 4-O-deacetylvinorelbine in human and mouse plasma using high-performance liquid chromatography coupled with heated electrospray ionization tandem mass-spectrometry.

Validation and application of a liquid chromatography-tandem mass spectrometric method for quantification of the drug transport probe fexofenadine in human plasma using 96-well filter plates.

Development and validation of a semi-automated assay for the highly sensitive quantification of Biolimus A9 in human whole blood using high-performance liquid chromatography-tandem mass spectrometry.

P304

e00131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRP2.131

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274141704

http://www.w3.org/2001/XMLSchema#string

P698

26038706

http://www.w3.org/2001/XMLSchema#string

P932

4448983

http://www.w3.org/2001/XMLSchema#string